Treatment of neuropathy

Details Treatment of neuropathy Treatment of neuropathy

A - Human Necessities

61

K

A61K 31/519 (2006.01) A61K 9/20 (2006.01) A61K 31/197 (2006.01) A61P 25/02 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2323839

This invention relates to the use of cyclic guanosine 3', 5'-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, in combination with gabapentin or pregabalin, which may be used for the treatment of neuropathy, including in particular the treatment of diabetic neuropathy.

Affiliated with

Also associated with

Rating

Treatment of neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neuropathy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1944931